Award

Taylor’s career began as a med school detour

She has won the 2022 Herbert Tabor Research Award
Nivedita Uday Hegdekar
Dec. 23, 2021

Susan Taylor’s career spans over 50 years of groundbreaking research, accolades and accomplishments. But she never intended to follow this path.

Susan Taylor

As a freshman at the University of Wisconsin, Taylor dreamed of becoming a physician. Charles Sorum, her chemistry professor, solidified her foundation in the field. “He was a big influence in my life and inspired me to major in chemistry, despite it being an unconventional choice for a woman in the 1960s,” Taylor said.

During her senior year, Taylor’s fiancé accepted a job at the National Institutes of Health in Maryland. Having missed the Johns Hopkins Medical School deadline, she applied to the Hopkins graduate school, where she completed doctoral research on lipids with Edward Heath and became a biochemist.

“I still had my heart set on medical school,” Taylor said. “However, my husband accepted a position in Cambridge, England, so I decided to hold off … for a few more years.”

As a postdoc with Brian Hartley at the Laboratory of Molecular Biology, Taylor found her life’s calling — protein chemistry and structural biology — and shelved her med school plans for good.

“My two years in Cambridge taught me how to think about science across disciplines and how to approach research problems as an interdisciplinary challenge,” she said.

Taylor returned to the U.S. as a postdoctoral fellow at the University of California, San Diego, where she remained and is now a distinguished professor in two departments: chemistry and biochemistry and pharmacology.

For her excellence in research and contributions to the scientific community, Taylor will receive the American Society for Biochemistry and Molecular Biology’s 2022 Herbert Tabor Research Award.

A passionate advocate for interdisciplinary science, especially for training the next generation of scientists, Taylor is especially conscientious about recruiting and mentoring underrepresented students.

She looks back fondly on her professional journey.

“I have had the good fortune of collaborating with so many creative scientists from various disciplines,” she said. “Over the years, we have supported and learned from each other.”

Fascination with a signaling molecule

When Susan Taylor was a postdoctoral fellow at the fledgling University of California, San Diego, her advisor, Nathan Kaplan, introduced her to cAMP-dependent protein kinase, or PKA, a signaling molecule that regulates glycogen, lipid metabolism and many other things within cells.

“I became fascinated with this highly allosteric enzyme and decided to characterize it further,” Taylor said. She and PKA became lifelong partners.

In her own lab, Taylor led studies that elucidated the structure and function of PKA. Following identification of active site residues in the catalytic and regulatory subunits, she and her collaborators solved the structure of the PKA C-subunit in 1991 - the first protein kinase structure. She subsequently solved structures of higher complexity, culminating in full-length functionally nonredundant holoenzymes.

Unraveling the dynamics and allosteric signaling and demonstrating how these correlate with disease phenotypes has been a continuing theme of the Taylor lab. Most recently, using high-resolution imaging in retina and brain, she has further defined isoform specificity and, in particular, has focused on the previously uncharacterized Cb isoform, which accounts for about 50% of PKA signaling in brain.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Nivedita Uday Hegdekar

Nivedita Uday Hegdekar is a recent Ph.D. graduate in biochemistry and molecular biology from the University of Maryland, Baltimore.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Fliesler wins scientific and ethical awards
Member News

Fliesler wins scientific and ethical awards

July 21, 2025

He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Feature

Before we’ve lost what we can’t rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

ASBMB members recognized as Allen investigators
Member News

ASBMB members recognized as Allen investigators

July 14, 2025

Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.

AI can be an asset, ASBMB educators say
Advice

AI can be an asset, ASBMB educators say

July 9, 2025

Pedagogy experts share how they use artificial intelligence to save time, increase accessibility and prepare students for a changing world.

ASBMB undergraduate education programs foster tomorrow’s scientific minds
Feature

ASBMB undergraduate education programs foster tomorrow’s scientific minds

July 8, 2025

Learn how the society empowers educators and the next generation of scientists through community as well as accreditation and professional development programs that support evidence-based teaching and inclusive pedagogy.